Key statistics
As of last trade, Legend Biotech Corp (9LB:BER) traded at 44.60, 23.20% above the 52 week low of 36.20 set on Jun 03, 2024.
52-week range
Open | 44.60 |
---|---|
High | 44.60 |
Low | 44.60 |
Bid | 43.20 |
Offer | 46.00 |
Previous close | 44.60 |
Average volume | 4.38 |
---|---|
Shares outstanding | 184.29m |
Free float | 181.21m |
P/E (TTM) | -- |
Market cap | 9.04bn USD |
EPS (TTM) | -1.57 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 08:50 BST.
More ▼
- Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
- CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
- Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights
- Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors
- Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024
- Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results
- Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma
More ▼